Answer
Aquipta (atogepant) is indicated for migraine prevention in adults who have at least 4 migraine days per month.
Sources for this answer
- AQUIPTA 10 mg tabletsAbbVie Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 6Document updated
Sources checked